REFERENCES
1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63.
2. Bergengren O, Pekala KR, Matsoukas K, et al. 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol. 2023;84:191-206.
3. Berenguer CV, Pereira F, Câmara JS, Pereira JAM. Underlying features of prostate cancer-statistics, risk factors, and emerging methods for its diagnosis. Curr Oncol. 2023;30:2300-21.
4. Charles LE, Loomis D, Shy CM, et al. Electromagnetic fields, polychlorinated biphenyls, and prostate cancer mortality in electric utility workers. Am J Epidemiol. 2003;157:683-91.
5. Dart D, Koushyar S, Uysal-onganer P. Exploring the potential link between prostate cancer and magnetic fields. Med Hypotheses. 2024;189:111384.
6. Baan R, Grosse Y, Lauby-Secretan B, et al; WHO International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of radiofrequency electromagnetic fields. Lancet Oncol. 2011;12:624-6.
7. Lange S, Inal JM, Kraev I, Dart DA, Uysal-onganer p. low magnetic field exposure alters prostate cancer cell properties. Biology. 2024;13:734.
8. Watson JM, Parrish EA, Rinehart CA. Selective potentiation of gynecologic cancer cell growth in vitro by electromagnetic fields. Gynecol Oncol. 1998;71:64-71.
9. Koh EK, Ryu BK, Jeong DY, Bang IS, Nam MH, Chae KS. A 60-Hz sinusoidal magnetic field induces apoptosis of prostate cancer cells through reactive oxygen species. Int J Radiat Biol. 2008;84:945-55.
10. Kiełbik A, Szlasa W, Novickij V, et al. Effects of high-frequency nanosecond pulses on prostate cancer cells. Sci Rep. 2021;11:15835.
11. Koreckij TD, Hill C, Azure L, et al. Low dose, alternating electric current inhibits growth of prostate cancer. Prostate. 2010;70:529-39.
12. Wang H, Guan Y, Li C, et al. PEGylated manganese-zinc ferrite nanocrystals combined with intratumoral implantation of micromagnets enabled synergetic prostate cancer therapy via ferroptotic and immunogenic cell death. Small. 2023;19:2207077.
13. Murat C, Kaya A, Kaya D, Erdoğan MA. Experimental study for in vitro prostate cancer treatment with microwave ablation and pulsed electromagnetic field. Electromagn Biol Med. 2024;43:135-44.
14. Attaluri A, Kandala SK, Wabler M, et al. Magnetic nanoparticle hyperthermia enhances radiation therapy: a study in mouse models of human prostate cancer. Int J Hyperthermia. 2015;31:359-74.
15. Rambo Martini A, Neris Cazella L, Martini Y, Viapiana Bossa A, Souza Santos J. Medicinal biomagnetismo in the treatment of prostate cancer: a case study. Health Soc. 2023;3:438-64.
16. Li X, Li Y, Xu J, et al. Terahertz wave desensitizes ferroptosis by inhibiting the binding of ferric ions to the transferrin. ACS Nano. 2025;19:6876-89.
17. Brabant C, Honvo G, Demonceau C, Tirelli E, Léonard F, Bruyère O. Effects of extremely low frequency magnetic fields on animal cancer and DNA damage: a systematic review and meta-analysis. Prog Biophys Mol Biol. 2025;195:137-56.
18. Murad HY, Yu H, Luo D, et al. Mechanochemical disruption suppresses metastatic phenotype and pushes prostate cancer cells toward apoptosis. Mol Cancer Res. 2019;17:1087-101.
19. Ma T, Ding Q, Liu C, Wu H. Electromagnetic fields regulate calcium-mediated cell fate of stem cells: osteogenesis, chondrogenesis and apoptosis. Stem Cell Res Ther. 2023;14:133.
20. Kurup R, Oakes EK, Manning AC, Mukherjee P, Vadlamani P, Hundley HA. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS. J Biol Chem. 2022;298:102267.
21. Sharma S, Wu SY, Jimenez H, et al. Ca2+ and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF. EBioMedicine. 2019;44:194-208.
22. Szasz A. Bioelectromagnetism for cancer treatment-modulated electro-hyperthermia. Curr Oncol. 2025;32:158.
23. Silvestri R, Nicolì V, Gangadharannambiar P, Crea F, Bootman MD. Calcium signalling pathways in prostate cancer initiation and progression. Nat Rev Urol. 2023;20:524-43.
24. Ardura JA, Álvarez-Carrión L, Gutiérrez-Rojas I, Alonso V. Role of calcium signaling in prostate cancer progression: effects on cancer hallmarks and bone metastatic mechanisms. Cancers. 2020;12:1071.
25. Daba MY, Fan Z, Li Q, Yuan X, Liu B. The role of calcium channels in prostate cancer progression and potential as a druggable target for prostate cancer treatment. Crit Rev Oncol Hematol. 2023;186:104014.
26. Marchetti C. Calcium signaling in prostate cancer cells of increasing malignancy. Biomol Concepts. 2022;13:156-63.
27. Srivastava M, Bera A, Eidelman O, et al. A dominant-negative mutant of ANXA7 impairs calcium signaling and enhances the proliferation of prostate cancer cells by downregulating the IP3 receptor and the PI3K/mTOR pathway. Int J Mol Sci. 2023;24:8818.
28. Dubois C, Vanden Abeele F, Lehen'kyi V, et al. Remodeling of channel-forming ORAI proteins determines an oncogenic switch in prostate cancer. Cancer Cell. 2014;26:19-32.
29. Liao J, Schneider A, Datta NS, McCauley LK. Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis. Cancer Res. 2006;66:9065-73.
30. Yang D, Kim J. Emerging role of transient receptor potential (TRP) channels in cancer progression. BMB Rep. 2020;53:125-32.
31. Lopez-Cavestany M, Hahn SB, Hope JM, et al. Matrix stiffness induces epithelial-to-mesenchymal transition via Piezo1-regulated calcium flux in prostate cancer cells. iScience. 2023;26:106275.
32. O’reilly D, Downing T, Kouba S, et al. CaV1. 3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer. bioRxiv 2021. https://www.biorxiv.org/content/10.1101/2021.09.03.458558v1.full (accessed 2025-08-08).
33. McLeod KJ. Microelectrode measurements of low frequency electric field effects in cells and tissues. Bioelectromagnetics. 1992;Suppl 1:161-78.
34. Bo W, Tang J, Ma J, Gong Y. Numerical study on calcium transport through voltage-gated calcium channels in response to nanosecond pulsed electric field. IEEE Trans Plasma Sci. 2018;46:2562-72.
35. Langthaler S, Zumpf C, Rienmüller T, et al. The bioelectric mechanisms of local calcium dynamics in cancer cell proliferation: an extension of the A549 in silico cell model. Front Mol Biosci. 2024;11:1394398.
36. Kaynak A, N'Guessan KF, Patel PH, et al. Electric fields regulate in vitro surface phosphatidylserine exposure of cancer cells via a calcium-dependent pathway. Biomedicines. 2023;11:466.
37. Kim YV, Conover DL, Lotz WG, Cleary SF. Electric field-induced changes in agonist-stimulated calcium fluxes of human HL-60 leukemia cells. Bioelectromagnetics. 1998;19:366-76.
38. Morabito C, Rovetta F, Bizzarri M, Mazzoleni G, Fanò G, Mariggiò MA. Modulation of redox status and calcium handling by extremely low frequency electromagnetic fields in C2C12 muscle cells: a real-time, single-cell approach. Free Radic Biol Med. 2010;48:579-89.
39. Van Huizen AV, Morton JM, Kinsey LJ, et al. Weak magnetic fields alter stem cell-mediated growth. Sci Adv. 2019;5:eaau7201.
40. Alipour M, Hajipour-Verdom B, Javan M, Abdolmaleki P. Static and electromagnetic fields differently affect proliferation and cell death through acid enhancement of ROS generation in mesenchymal stem cells. Radiat Res. 2022;198:384-95.
41. Ghabili K, Shoja MM, Agutter PS. Piezoelectricity and prostate cancer: proposed interaction between electromagnetic field and prostatic crystalloids. Cell Biol Int. 2008;32:688-91.
42. Kiełbik A, Szlasa W, Michel O, et al. In vitro study of calcium microsecond electroporation of prostate adenocarcinoma cells. Molecules. 2020;25:5406.
43. Gorobets O, Gorobets S, Polyakova T, et al. Modulation of calcium signaling and metabolic pathways in endothelial cells with magnetic fields. Nanoscale Adv. 2024;6:1163-82.
44. Lucke-Wold BP, Logsdon AF, Turner RC, Huber JD, Rosen CL. Endoplasmic reticulum stress modulation as a target for ameliorating effects of blast induced traumatic brain injury. J Neurotrauma. 2017;34:S62-70.
45. Hu C, Chen Q, Wu T, et al. The role of extracellular vesicles in the treatment of prostate cancer. Small. 2024;20:2311071.
46. Tai YL, Lin CJ, Li TK, Shen TL, Hsieh JT, Chen BPC. The role of extracellular vesicles in prostate cancer with clinical applications. Endocr Relat Cancer. 2020;27:R133-44.
47. Ludwig M, Rajvansh R, Drake JM. Emerging role of extracellular vesicles in prostate cancer. Endocrinology. 2021:162.
48. Jain DP, Dinakar YH, Kumar H, Jain R, Jain V. The multifaceted role of extracellular vesicles in prostate cancer-a review. Cancer Drug Resist. 2023;6:481-98.
49. Ghafouri-Fard S, Shoorei H, Taheri M. Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer. Gene. 2020;759:144995.
50. Doghish AS, Ismail A, El-Mahdy HA, Elkady MA, Elrebehy MA, Sallam AM. A review of the biological role of miRNAs in prostate cancer suppression and progression. Int J Biol Macromol. 2022;197:141-56.
51. Gujrati H, Ha S, Wang BD. Deregulated microRNAs involved in prostate cancer aggressiveness and treatment resistance mechanisms. Cancers. 2023;15:3140.
52. Liu H, Geng Z, Su J. Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy. Extracell Vesicles Circ Nucl Acids. 2022;3:63-86.
53. Lázaro-Ibáñez E, Neuvonen M, Takatalo M, et al. Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles. J Extracell Vesicles. 2017;6:1354645.
54. El-Sayed IY, Daher A, Destouches D, et al. Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling. Cancer Lett. 2017;410:100-11.
55. Souza AG, B Silva IB, Campos-Fernández E, et al. Extracellular vesicles as drivers of epithelial-mesenchymal transition and carcinogenic characteristics in normal prostate cells. Mol Carcinog. 2018;57:503-11.
56. Hosseini-Beheshti E, Choi W, Weiswald LB, et al. Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment. Oncotarget. 2016;7:14639-58.
57. Probert C, Dottorini T, Speakman A, et al. Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis. Oncogene. 2019;38:1751-63.
58. Liu H, Wu Y, Wang F, et al. Bone-targeted engineered bacterial extracellular vesicles delivering miRNA to treat osteoporosis. Compos Part B Eng. 2023;267:111047.
59. Sun ZC, Ge JL, Guo B, et al. Extremely low frequency electromagnetic fields facilitate vesicle endocytosis by increasing presynaptic calcium channel expression at a central synapse. Sci Rep. 2016;6:21774.
60. Zhang X, Liu X, Pan L, Lee I. Magnetic fields at extremely low-frequency (50 Hz, 0.8 mT) can induce the uptake of intracellular calcium levels in osteoblasts. Biochem Biophys Res Commun. 2010;396:662-6.
61. Karabakhtsian R, Broude N, Shalts N, Kochlatyi S, Goodman R, Henderson AS. Calcium is necessary in the cell response to EM fields. FEBS Lett. 1994;349:1-6.
62. Gohji K, Fujimoto N, Hara I, et al. Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer. 1998;79:96-101.
63. Moses MA, Wiederschain D, Loughlin KR, Zurakowski D, Lamb CC, Freeman MR. Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res. 1998;58:1395-9.
64. Mehdizadeh R, Madjid Ansari A, Forouzesh F, et al. Cross-talk between non-ionizing electromagnetic fields and metastasis; EMT and hybrid E/M may explain the anticancer role of EMFs. Prog Biophys Mol Biol. 2023;182:49-58.
65. Moori M, Norouzian D, Yaghmaei P, Farahmand L. Electromagnetic field as a possible inhibitor of tumor invasion by declining E-cadherin/N-cadherin switching in triple negative breast cancer. Electromagn Biol Med. 2024;43:236-45.
66. Wang S, Wei W, Ma N, Qu Y, Liu Q. Molecular mechanisms of ferroptosis and its role in prostate cancer therapy. Crit Rev Oncol Hematol. 2022;176:103732.
67. Huang M, Teng Q, Cao F, Huang J, Pang J. Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer. Biomater Sci. 2024;12:1617-29.
68. Liang J, Liao Y, Wang P, et al. Ferroptosis landscape in prostate cancer from molecular and metabolic perspective. Cell Death Discov. 2023;9:128.
69. Panther EJ, Zelmanovich R, Hernandez J, Dioso ER, Foster D, Lucke-Wold B. Ferritin and Neurotoxicity: a contributor to deleterious outcomes for subarachnoid hemorrhage. Eur Neurol. 2022;85:415-23.
70. Franco-Obregón A. Harmonizing magnetic mitohormetic regenerative strategies: developmental implications of a calcium-mitochondrial axis invoked by magnetic field exposure. Bioengineering. 2023;10:1176.
71. Stejerean-Todoran I, Gibhardt CS, Bogeski I. Calcium signals as regulators of ferroptosis in cancer. Cell Calcium. 2024;124:102966.
72. Wu Y, Song Y, Wang R, Wang T. Molecular mechanisms of tumor resistance to radiotherapy. Mol Cancer. 2023;22:96.
73. Wisdom AJ, Hong CS, Lin AJ, et al. Neutrophils promote tumor resistance to radiation therapy. Proc Natl Acad Sci U S A. 2019;116:18584-9.
74. Wang F, Dai Q, Xu L, et al. Advances on the role of ferroptosis in ionizing radiation response. Curr Pharm Biotechnol. 2024;25:396-410.
75. Chen J, Wang Y, Han L, et al. A ferroptosis-inducing biomimetic nanocomposite for the treatment of drug-resistant prostate cancer. Mater Today Bio. 2022;17:100484.
76. Lei G, Zhang Y, Koppula P, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020;30:146-62.
77. Wang S, Luo J, Zhang Z, et al. Iron and magnetic: new research direction of the ferroptosis-based cancer therapy. Am J Cancer Res. 2018;8 10:1933-46.
78. Brain JD, Kavet R, McCormick DL, et al. Childhood leukemia: electric and magnetic fields as possible risk factors. Environ Health Perspect. 2003;111:962-70.
79. Mohammadi H, Dehghan SF, Moradi N, et al. Assessment of sexual hormones in foundry workers exposed to heat stress and electromagnetic fields. Reprod Toxicol. 2021;101:115-23.
80. Kuzmina LP, Kisljakova AA, Bezrukavnikova LM, Khotuleva AG, Varakuta AL. The influence of electromagnetic fields of industrial frequency on the male reproductive system. Russ J Occup Health Ind Ecol. 2022;62:397-402.
81. Li JH, Jiang DP, Wang YF, et al. Influence of electromagnetic pulse on the offspring sex ratio of male BALB/c mice. Environ Toxicol Pharmacol. 2017;54:155-61.
82. Kozlowska W, Drzewiecka EM, Zmijewska A, Koziorowska A, Franczak A. Effects of electromagnetic field (EMF) radiation on androgen synthesis and release from the pig endometrium during the fetal peri-implantation period. Anim Reprod Sci. 2021;226:106694.
